Phase 2 Metastatic Esophageal Squamous Cell Carcinoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Esophageal CancerEsophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital100 enrolled2 locationsNCT05978193
Recruiting
Phase 2
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Urothelial CarcinomaEsophageal CarcinomaHepatocellular Carcinoma+28 more
Mayo Clinic50 enrolled1 locationNCT06265285
Recruiting
Phase 2Phase 3
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
Metastatic Esophageal Squamous Cell Carcinoma
Qingdao Central Hospital90 enrolled2 locationsNCT06138028
Recruiting
Phase 2
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University32 enrolled1 locationNCT06339619